April 18th, 2025
Coronavirus Updates - Page 6
GAVI Vaccine Alliance Says $40 Would Be Maximum Price for COVID-19 Vaccine
By Darya Rudz
July 28th, 2020
There is a number of factors that will affect the COVID-19 vaccine price. They include technology, single or a double vaccine dose, as well as what yields from manufacturing facilities might be.
Republicans Unveil Second Round of COVID-19 Stimulus Plan, Final Decision by July 31
By Bhushan Akolkar
July 28th, 2020
Amidst the ongoing economic and healthcare crisis, the Republican Party in the U.S. has unveiled the second round of stimulus package plan. The government is willing to pass the legislation by July 31 and has sought support from the Democratic Party for proceeding ahead.
AZN Stock Lost 4% while AstraZeneca Coronavirus Vaccine Shows Positive Results in Early Trials
By Godfrey Benjamin
July 21st, 2020
Data from AstraZeneca’s clinical trials of its COVID-19 vaccine candidate AZD1222 shows promising results but AZN share price has refused to be positively impacted.
Second Wave of U.S. $1,200 Stimulus Checks Coming Soon? Important Things You Need to Know
By Christopher Hamman
July 21st, 2020
The next round of U.S. stimulus checks may come really soon. The only issue here is how fast Republicans and Democrats will come to an agreement.
SNG Stock Soars 470% as Synairgen Reports Promising COVID-19 Vaccine Trial Results
By Darya Rudz
July 20th, 2020
Following the company’s announcement about the success of its COVID-19 vaccine, Synairgen stock has increased significantly. Now it is nearly 470% up.
Gold Prices Fall after Hitting Record $1,800: Is It Worth Investing?
By Darya Rudz
July 20th, 2020
This year the gold price is 18.38% up. Analysts are predicting further growth. At the moment of writing, it is trading $1,810.40 per ounce.
JNJ Stock Up 0.67% as Johnson & Johnson Wants to Begin Late-Stage COVID-19 Vaccine Trial in September
By Christopher Hamman
July 17th, 2020
Johnson & Johnson (JNJ) stock price is rising as the company is moving forward with its vaccine trials.
MRNA Stock Up 18% in Pre-market, Moderna Has Good News about Its Coronavirus Vaccine
By Steve Muchoki
July 15th, 2020
Moderna (MRNA) stock is up over 18% in the pre-market after adding 4.54% yesterday. The spike is attributed to the announcement that the coronavirus vaccine trial demonstrated a robust immune response.
Group of Millionaires Asks Governments to Raise Taxes for Them to Ensure Coronavirus Recovery
By Steve Muchoki
July 14th, 2020
In a letter dubbed ‘Millionaires for Humanity’, a group of global millionaires asked governments to raise taxes for people like them to deal with the COVID-19 impact.
Pfizer (PFE), BioNTech (BNTX) Stocks Surge, Their Coronavirus Vaccine Candidates Get ‘Fast Track’ Designation
By Tolu Ajiboye
July 13th, 2020
Pfizer and BioNTech stocks have jumped in response to receiving ‘Fast Track’ status on their coronavirus vaccine candidates. PFE and BNTX prices are rising.
GILD Stock Lost 1% Yesterday, Gilead Starts Early-Stage Trial for Its Remdesivir Drug
By Steve Muchoki
July 9th, 2020
Gilead Sciences (GILD) stock is slightly down despite the progress that the company made in testing of its remdesivir drug that can be used as the coronavirus treatment.
NVAX Stock Price Up 35% Now as Novavax Gets $1.6 Billion Grant for COVID-19 Vaccine Development
By Christopher Hamman
July 7th, 2020
NVAX stock price is skyrocketing these days as Novavax is getting one step closer to the development of its coronavirus vaccine.
Wall Street Goes Bullish on Strong Services Sector amidst Hope of China’s Recovery
By Godfrey Benjamin
July 7th, 2020
Last week’s growth in Chinese markets has spiked a bullish run in U.S Wall Street. Hopes for a full economic recovery are gaining momentum.
Chinese Government Is Using Its Media to Boost Stock Market
By Godfrey Benjamin
July 7th, 2020
The Shanghai stock market that gained nearly 6% last week has managed to add another 5.7% after that report.
JPMorgan Says Joe Biden’s Win in U.S. Presidential Election Could Be Positive for Stock Market
By Bhushan Akolkar
July 7th, 2020
Against the popular opinion, JPMorgan says that a win of Joe Biden in the U.S. Presidential Election 2020 could be a positive for the markets. JPMorgan predicts that his victory can ease tariffs on China and boost infrastructure spending.